El.En. SpA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IT0005453250
EUR
13.08
0.05 (0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About El.En. SpA stock-summary
stock-summary
El.En. SpA
Pharmaceuticals & Biotechnology
El En SpA is an Italy-based company primarily engaged in the production of laser systems. It controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The Company also offers accessories, after-sale services and consulting in the related areas.
Company Coordinates stock-summary
Company Details
Via Baldanzese, 17 , CALENZANO None : 50041
stock-summary
Tel: 39 055 882680739 055 8826807
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Eng. Gabriele Clementi
Chairman of the Board, President, Managing Director
Ms. Barbara Bazzocchi
Managing Director, Executive Director
Eng. Andrea Cangioli
Managing Director, Executive Director
Dr. Alberto Pecci
Non-Executive Director
Mr. Michele Legnaioli
Non-Executive Independent Director
Ms. Fabia Romagnoli
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
50 Million
(Quarterly Results - Dec 2013)
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 1,037 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

13,046.87%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.71